66 related articles for article (PubMed ID: 6733256)
1. Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine.
Robinson Y; Gerry N; Brownsill RD; Vose CW
Biomed Mass Spectrom; 1984 Apr; 11(4):199-201. PubMed ID: 6733256
[TBL] [Abstract][Full Text] [Related]
2. [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine].
Kaul R; Hempel B
Arzneimittelforschung; 1985; 35(7):1055-7. PubMed ID: 4052140
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.
Cheraghali AM; Kumar R; Knaus EE; Wiebe LI
Drug Metab Dispos; 1995 Feb; 23(2):223-6. PubMed ID: 7736915
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma.
Robinson Y; Gerry N; Vose CW
J Chromatogr; 1985 Feb; 338(1):219-24. PubMed ID: 4019647
[No Abstract] [Full Text] [Related]
5. The synthesis and properties of some 5-substituted uracil derivatives.
Walker RT; Jones AS; Rahim SG; Serafinowski P; De Clercq E
Nucleic Acids Symp Ser; 1981; (9):21-4. PubMed ID: 7301597
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic studies of epervudine in rats using HPLC].
Dereszlay I; Mészáros S; Csárdi A; Pátfalusi M; Vereczkey L
Acta Pharm Hung; 1993 Jul; 63(4):227-36. PubMed ID: 8379339
[TBL] [Abstract][Full Text] [Related]
8. Antiviral and antitumor activities of 5-substituted 2'-deoxyuridines.
De Clercq E
Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):253-67. PubMed ID: 6765587
[No Abstract] [Full Text] [Related]
9. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
Chen IW; Lin JH
Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
[TBL] [Abstract][Full Text] [Related]
10. Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus).
Pollock CG; Carpenter JW; Koch DE; Hunter RP
J Vet Pharmacol Ther; 2008 Apr; 31(2):171-4. PubMed ID: 18307510
[TBL] [Abstract][Full Text] [Related]
11. The disposition of acyclovir in different species.
de Miranda P; Krasny HC; Page DA; Elion GB
J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antisera to 5-(2-bromo-E-ethenyl)-2'-deoxyuridine for the radioimmunoassay of a potent antiviral agent.
Jackson LS; Stafford JE
J Pharmacol Methods; 1989 Sep; 22(2):125-32. PubMed ID: 2811389
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of 5-ethyl-2'-desoxyuridine in the rat].
Hempel B; Kaul R
Arzneimittelforschung; 1985; 35(7):1058-60. PubMed ID: 4052141
[TBL] [Abstract][Full Text] [Related]
14. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic studies of 14C-labeled epervudine in rats].
Dereszlay I; Vereczkey L
Acta Pharm Hung; 1993 Jul; 63(4):222-6. PubMed ID: 8379338
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of anti-herpes agent 5-(2-chloroethyl)-2'-deoxyuridine in mice and rats.
Szinai I; Veres Z; Ganzler K; Hegedus-Vajda J; De Clercq E
Eur J Drug Metab Pharmacokinet; 1991; 16(2):129-36. PubMed ID: 1936072
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of 5-ethyl-2'-deoxyuridine and its 5,6-dihydro prodrugs in murine lung and its potential clinical application.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
J Pharm Pharmacol; 1995 Jul; 47(7):595-600. PubMed ID: 8568628
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of geometric isomers of a phosphodiesterase inhibitor in rat and monkey plasma using liquid chromatography-tandem mass spectrometry.
Liang Y; Zhang R; Adarayan E; Adamson G; Zhao JJ; Kassahun K; Emary WB
J Pharm Biomed Anal; 2006 Jun; 41(4):1293-8. PubMed ID: 16563689
[TBL] [Abstract][Full Text] [Related]
19. Determination of acyclovir in horse plasma and body fluids by high-performance liquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry.
Maes A; Garré B; Desmet N; van der Meulen K; Nauwynck H; De Backer P; Croubels S
Biomed Chromatogr; 2009 Feb; 23(2):132-40. PubMed ID: 18823074
[TBL] [Abstract][Full Text] [Related]
20. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
